Mr. Speaker, our government has demonstrated its commitment to improving the accessibility and affordability of prescription drugs, including joining with provinces and territories to negotiate drug prices through the pan-Canadian pharmaceutical alliance, but we recognize that there is an opportunity to do even more.
The advisory council on the implementation of national pharmacare is engaging with Canadians and assessing options to provide our government with independent advice on how best to implement a national pharmacare program in a manner that is affordable for Canadians, employers and governments. The work of the council will be fundamental in ensuring that Canadians have access to the drug therapies they need at an affordable cost. I look forward to the council's final report next spring, which will guide the government in moving forward on national pharmacare.